Search - tctmd.com

Displaying 1 - 15 of 15

Sort: Relevancy | Date

SUMMIT: Tirzepatide ‘Huge Win’ for HFpEF Patients With Obesity

News Conference News AHA 2024

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Michael O'Riordan

November 16, 2024

News Features

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Michael O'Riordan

October 21, 2024

News Daily News

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Caitlin E. Cox

October 04, 2024

News Conference News HFSA 2024

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Todd Neale

October 01, 2024

News Daily News

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Todd Neale

June 26, 2024

News Features

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

L.A. McKeown

May 12, 2023

News Daily News

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

Michael O'Riordan

July 05, 2022

News Daily News

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Shelley Wood

July 12, 2021

News Daily News

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Michael O'Riordan

April 26, 2021

News Daily News

Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD

Shelley Wood

August 14, 2020

News Daily News

New AHA Advisory Waffles on Artificially Sweetened Drinks, Citing Dearth of Studies

Lucy Hicks

August 07, 2018

News Daily News

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Michael O'Riordan

January 30, 2018

News Daily News

Proximity to Physical Activity Facilities May Play Role in Body Fat Levels

Michael O'Riordan

December 13, 2017

News Daily News

Apples and Pears: Genetic Analysis Points to Causal Role for Belly Fat in Heart Disease and Diabetes

Yael L. Maxwell

February 14, 2017

News Daily News

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

L.A. McKeown

December 09, 2015

Advertisement

SUMMIT: Tirzepatide a ‘Huge Win’ for HFpEF Patients With Obesity

Can ‘Body Roundness Index’ Replace BMI? That Depends, Say Experts

Time-Restricted Eating Tightens Glycemic Control in Patients With Metabolic Syndrome

Semaglutide Helps in HFpEF Irrespective of Frailty, Exercise Capacity

Semaglutide Has Similar Benefits in Women and Men With HFpEF

Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar

‘Code Blue’ for the Dire CVD Health Status of Most US Adults

ASCVD Risk in South Asians Far Exceeds Forecasts by Common Scores

Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA

Obesity’s Role in COVID-19 Deaths: ‘Profound’ and Independent of CVD

New AHA Advisory Waffles on Artificially Sweetened Drinks, Citing Dearth of Studies

‘Call to Action’ in India, Where Hypertension and Diabetes Loom Large

Proximity to Physical Activity Facilities May Play Role in Body Fat Levels

Apples and Pears: Genetic Analysis Points to Causal Role for Belly Fat in Heart Disease and Diabetes

AHA Scientific Statement Highlights Sex Disparities in CV Risk Among Diabetic Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content